FDA Alert: Orlistat (marketed as Alli and Xenical): Early Communication about an Ongoing Safety Review
Links shared publicly online about this topic.
- 1,797total visits
FDA Alert: Orlistat (marketed as Alli and Xenical): Early Communication about an Ongoing Safety Review
FDA Alert: Orlistat (marketed as Alli and Xenical): Early Communication about an Ongoing Safety Review
View full resource at drugs.com
Tags: Liver, Liver Condition, Liver Failure, Obesity Medication, Weight Loss, Drug, FDA, Xenical
Most Recently Shared on August 25, 2009 at 10:08 pm By:
FDA Alert - FDA Reviewing Reports of Liver Failure with Weight Loss Drug Orlistat (marketed as Alli and Xenical) - http://bit.ly/3E8nyv
Advertisement
